Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
New ways to improve breast cancer therapy targeting specific molecular pathways
John P. Schwerkoske,
Douglas Yee
Medicine - Hematology, Oncology, Transplant
Office of Academic Clinical Affairs
Cellular Mechanisms of Cancer
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New ways to improve breast cancer therapy targeting specific molecular pathways'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Breast Cancer Treatment
100%
Clinical Trials
50%
Growth Hormone Receptor
50%
Hormone Receptor-positive
50%
Kinase Cascade
50%
Laboratory Science
50%
Molecular Pathways
100%
Monoclonal Antibody
50%
New Drugs
50%
New Targets
100%
Phosphatidylinositol 3-kinase Signaling
50%
Signaling Pathway
50%
Small Molecules
50%
Triple-negative Breast Cancer
50%
Tyrosine Kinase Inhibitor
50%
Medicine and Dentistry
Breast Cancer
100%
Cancer Therapy
100%
Cell Signaling Pathway
100%
Clinical Trial
50%
Growth Factor Receptor
50%
Hormone Receptor
50%
Kinase Signaling
50%
Monoclonal Antibody
50%
Phosphoinositide 3-Kinase
50%
Triple Negative Breast Cancer
50%
Tyrosine-Kinase Inhibitor
50%